Not checked for notices yet.
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.
Robert A Wise, Janet T Holbrook, Gerard Criner and 13 more
PLoS ONE · 2016
doi:10.1371/journal.pone.0163716
Cited by papers we hold 5
- Biomarkers of NRF2 signalling: Current status and future challenges · 2024No notice
- Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging · 2023No notice
- Progress in the mechanism and targeted drug therapy for COPD · 2020No notice
- Role of Nrf2 and Its Activators in Respiratory Diseases · 2019No notice
- Broccoli or Sulforaphane: Is It the Source or Dose That Matters? · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.